172
I. Moldes et al. / Journal of Organometallic Chemistry 566 (1998) 165–174
5.4.3. Complex 7
(d, JPC=1.0, CH cym), 87.4 (d, JPC=1.4, CH cym),
41.9 (d, JPC=21.1 Hz; CH2),30.7 (s, CHMe2), 21.9 (s,
CHMe2), 22.2 (s, CHMe2), 17.7 (s, CMe) ppm.
31P{1H}-NMR (CDCl3 sol.): 54.0 (s) ppm.
Anal. Calc. for C21H31Cl2PRu: C, 61.40; H, 5.09.
Found: C, 60.40; H, 5.12%. 1H-NMR (CDCl3 sol.):
7.54 (m, 10H, Ph), 7.43 (d, JHH=8.0 Hz; 2H, Tol), 7.13
(d, JHH=8.0 Hz; 2H, Tol), 5.16, 5.24 (2m, 4H, H cym),
2.83 (sept, JHH=6.9 Hz; 1H, CHMe2), 2.31 (s, 3H,
Tol), 1.87 (s, 3H, Me), 1.07 (d, JHH=6.9 Hz; 6H,
CHMe2) ppm. 13C{1H}-NMR (CDCl3 sol.): 133.0–
128.5 (Ph), 117.5 (d, JPC=3.7 Hz; Cp-Tol), 109.2
(CCHMe2), 95.7 (s, CMe), 90.1(s, CH cym), 86.3 (d,
5.7. Synthesis of [RuCl2(p-cymene)(PPh2CꢀCPPh2)]
(10)
A 100 mg (0.16 mmol) sample of [RuCl2(p-cymene)]2
(1) was mixed with 64 mg (0.16 mmol) of
PPh2CꢀCPPh2 in 15 ml of dichloromethane. The mix-
ture was stirred for 20 h at r.t. and the solvent was
evaporated to dryness in vacuo. The residue was
washed several times with hexane and the resulting
solid was crystallized in a dichloromethane–hexane
mixture. Compound 10 was obtained as a red solid
(yield 96 mg, 60%). Anal. Calc. for C46H28Cl2PRu (2
CH2Cl2): C, 48.98; H, 4.42. Found: C, 48.87; H, 4.37%.
1H-NMR (CDCl3 sol.): 7.61 (m, 20H, Ph), 5.31 (m, 8H,
H cym), 2.43 (sept, JHH=6.9 Hz; 2H, CHMe2), 1.70 (s,
6H, Me), 0.94 (d, JHH=6.9 Hz; 12H, CHMe2) ppm.
13C{1H}-NMR (CDCl3 sol.): 133.5–128.3 (Ph), 109.9
(CCHMe2), 103.1 (d, JPC=76.5 Hz; PPh2C), 98.6 (s,
JPC=5.5, CH cym), 88.6 (d, JPC=91.6 Hz; PPh2C),
30.0 (s, CCHMe2), 21.3 (s, Tol), 21.6 (s, CHMe2), 17.2
(s, CMe) ppm. 31P{1H}-NMR (CDCl3 sol.): −2.3 (s)
ppm. IR (KBr): w(CꢀC) 2168 cm−1
.
5.5. Synthesis of [RuCl(p-cymene)(PPh2Py)][BF4] (8)
A solution of 25 mg (0.22 mmol) of NaBF4 in 10 ml
of methanol was added to a solution of 130 mg (0.23
mmol) of compound 3 in 10 ml of dichloromethane.
The mixture was stirred for 10 h at r.t. The solvent was
removed in vacuo, the residue was dissolved in 5 ml of
dichloromethane and filtered off and methanol was
added. Cooling to −20°C induced the formation of
120 mg (85% yield) of compound 8. Anal. Calc. for
C27H28BClF4NPRu: C, 52.25; H, 4.57; N, 2.26. Found:
CMe), 89.1 (d, JPC=4.8 Hz; CH cym), 87.0 (d, JPC
=
3.5, CH cym), 30.2 (s, CHMe2), 21.8 (s, CHMe2), 17.4
(s, CMe) ppm. 31P{1H}-NMR (CDCl3 sol.): 10.1 (s)
ppm. IR (KBr): w(CꢀC) not observed.
1
C, 52.34; H, 4.78; N, 2.37%. H-NMR (CDCl3 sol.):
8.79 (m, 1H, py), 7.30 (m, 10H, Ph), 7.90, (m, 3H, py),
5.46, 5.42, 5.32, 5.30 (4m, 4H, H cym), 2.53 (sept,
5.8. Catalytic hydrogenation reactions
J
J
HH=6.9 Hz; 1H, CHMe2), 1.61 (s, 3H, Me), 0.84 (d,
HH=6.9 Hz; 6H, CHMe2) ppm. 13C{1H}-NMR
All catalytic experiments were performed in a 100 ml
home-built stainless steel autoclave equipped with gas
and liquid inlets, heating device and magnetic stirrer. In
a typical experiment, a solution of the catalyst precur-
sor 3 or 8 (0.1 mmol) and the organic substrate (styrene
or phenylacetylene) (20 mmol) in 20 ml of
dichloromethane was placed into the reactor under
nitrogen and the autoclave was pressurized with H2.
(CDCl3 sol.): 154.9 (d, JPC=16.5 Hz; py), 139.0–128.6
(Ph+py), 111.0 (d, JPC=3.7 Hz; CCHMe2), 101.9 (s,
CMe), 84.8 (d, JPC=1.8 Hz; CH cym), 85.8 (d, JPC
=
1.8 Hz; CH cym), 88.1 (d, JPC=4.6 Hz; CH cym), 88.2
(d, JPC=4.6 Hz; CH cym), 28.9 (s, CHMe2), 22.3 (d,
J
PC=7.3 Hz; CHMe2), 22.6 (d, JPC=7.3 Hz; CHMe2),
18.3 (s, CMe) ppm. 31P{1H}-NMR (CDCl3 sol.): −
17.4 (s) ppm.
5.9. X-ray structure determination and refinement of
complexes 2, 3 and 8
5.6. Synthesis of [RuCl(p-cymene)(PPh2CH2Py)][BF4]
(9)
5.9.1. Crystal data
Following the same procedure and using 150 mg
(0.23 mmol) of [RuCl2(p-cymene)(PPh2CH2Py)] (4), yel-
low crystals of compound 9 were obtained (yield 115
mg, 70%). Anal. Calc. for C28H30BClF4NPRu: C, 52.97;
H, 4.73; N, 2.21. Found: C, 52.85; H, 4.75; N, 1.97%.
1H-NMR (CDCl3 sol.): 9.39 (m, 1H, py), 7.40 (m, 13H,
Ph+py), 5.66, 5.70, 5.78, 5.82 (4m, 4H, H cym), 4.10
(d, JPH=12.4 Hz; 2H, PCH2), 2.63 (sept, JHH=6.9 Hz;
1H, CHMe2), 1.58 (s, 1H, Me), 0.88 (d, JHH=6.9 Hz;
6H, CHMe2) ppm. 13C{1H}-NMR (CDCl3 sol.): 161.9
(d, JPC=2.6 Hz; py), 158.8 (s, py), 140.4–124.5 (Ph+
py), 113.8 (s; CCHMe2), 103.8 (s, CMe), 92.1 (d,
Crystals of 2, 3 or 8 suitable for X-ray diffraction
analysis were obtained by recrystallization in
dichlorometane–hexane mixtures at −20°C.
Compound 2: C22H25Cl2PRu; M=492.36. Mono-
˚
clinic; a=10.394(1), b=11.741(3), c=17.472(2) A,
3
˚
i=97.02(1)°; V=2116.2(6) A (by least-squares refine-
ment on diffractometer angles for 25 automatically
˚
centred reflections, u=0.71069 A), space group P21/c
(no. 14), Z=4; Dcalc. =1.545 g cm−3. Red, air-stable
crystals, v(Mo–Kh)=10.7 cm−1
.
Compound 3: C27H28Cl2NPRu, M=569.44. Tri-
˚
clinic, a=10.514(1), b=10.940(2), c=13.301(2) A,
JPC=3.4, CH cym), 90.9 (d, JPC =3.4, CH cym), 88.1
h=66.80(1), i=88.87(1), k=66.82(1)°, V=1276.0(4)